-
Comparative Efficacy of Asciminib vs. Second-Generation TKIs in Newly Diagnosed PhCML Using Unanchored Matching-Adjusted Indirect Comparisons
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Etrasimod, Ozanimod, and Adalimumab Compared to Infliximab in Treatment-Naive Patients With Moderate to Severe Ulcerative Colitis
Sep 9, 2025, 16:22 PM -
Bimekizumab’s Synergistic Economic Impact Across Four Indications in France
Sep 9, 2025, 16:22 PM -
Development and Implementation of a Dynamic Framework for Assessment and Improvement of Registries’ Data Quality
Sep 9, 2025, 16:22 PM -
Common Criticism of Patient-Reported Outcomes (PRO) in Health Technology Assessments (HTA) by the Institute for Quality and Efficiency in Healthcare (IQWiG) in Breast Cancer and Non-Small Cell Lung Cancer (NSCLC)
Sep 9, 2025, 16:22 PM -
Addressing the Inherent Challenges of the French National Claims Database (SNDS) Through Algorithms to Identify Patients With Diffuse Large B-cell Lymphoma (DLBCL) and Their Chemotherapy Treatments
Sep 9, 2025, 16:22 PM -
Saving Money Improving Outcomes: A Two-Year Cost-Utility Analysis of Emergency Department Care Models for Managing Persons Presenting With a Musculoskeletal Disorder
Sep 9, 2025, 16:22 PM -
Pharosight: A Shiny-Based Interactive Platform With LLM-Enhanced Analyses and Predictive Modeling for Real-World Prescription Data
Sep 9, 2025, 16:22 PM -
Epidemiological Characteristics and Economic Burden of IgA Nephropathy—a Retrospective Study Using Multicenter Electronic Medical Records Data in China
Sep 9, 2025, 16:22 PM -
Reassessing NICE's Highly Specialized Technologies (HST) Criteria: A Retrospective Review of Borderline and Approved Appraisals Under the Revised Framework
Sep 9, 2025, 16:22 PM -
The Estimation of the Prevalent Presymptomatic Type 1 Diabetes Population in Germany Using a Patient Funnel Model
Sep 9, 2025, 16:22 PM -
Trends in Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Prescribing in England: A Data Analysis Using NHS Prescription Episodes Statistics (PES)
Sep 9, 2025, 16:22 PM -
How the NHS Can Optimize Health Outcomes in a Time of Financial Constraint
Sep 9, 2025, 16:22 PM -
Medical and Nonmedical Resource Utilization Associated With CIDP: Results From a Real-World International Survey
Sep 9, 2025, 16:22 PM -
Utility Estimates for Health States Associated With Immune Thrombocytopenia: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Retrospective Analysis of Hungarian HTA Submissions Under the Former National Health Economics Guideline
Sep 9, 2025, 16:22 PM -
Development of Two Versions of a Patient-Reported Outcome Measure to Evaluate Participant Experience and Satisfaction During the Intervention and Analytical Treatment Interruption Periods of Cure-Related and Other HIV Trials
Sep 9, 2025, 16:22 PM -
Does Insurance Value in Metastatic Breast Cancer Vary by Age Testing for Variation in Willingness to Pay for Novel Treatments Among Women in the US?
Sep 9, 2025, 16:22 PM -
Inequality in Vaccine Uptake: Lessons Learned From Denmark Analyzing Real-World Data From National Registries
Sep 9, 2025, 16:22 PM -
Cardiovascular Effects of Semaglutide in Patients With Obesity, With or Without Type 2 Diabetes (T2DM): An Umbrella Review
Sep 9, 2025, 16:22 PM
